NL122039C - - Google Patents

Info

Publication number
NL122039C
NL122039C NL122039DA NL122039C NL 122039 C NL122039 C NL 122039C NL 122039D A NL122039D A NL 122039DA NL 122039 C NL122039 C NL 122039C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL122039C publication Critical patent/NL122039C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL122039D 1960-10-20 NL122039C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63736A US3080294A (en) 1960-10-20 1960-10-20 Sustained release type of pharmaceutical vehicles

Publications (1)

Publication Number Publication Date
NL122039C true NL122039C (en)

Family

ID=22051148

Family Applications (2)

Application Number Title Priority Date Filing Date
NL270408D NL270408A (en) 1960-10-20
NL122039D NL122039C (en) 1960-10-20

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL270408D NL270408A (en) 1960-10-20

Country Status (6)

Country Link
US (1) US3080294A (en)
BE (1) BE659324A (en)
CH (1) CH423100A (en)
DE (1) DE1467961A1 (en)
GB (1) GB935602A (en)
NL (2) NL122039C (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (en) * 1961-01-31
BE627516A (en) * 1962-01-25
US3159544A (en) * 1963-02-11 1964-12-01 Smith Kline French Lab Method of printing pharmaceutical forms and product thereof
US3282790A (en) * 1963-05-31 1966-11-01 Upjohn Co Enteric coated tablet
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
FR1396710A (en) * 1964-06-15 1965-04-23 Diwag Chemische Fabriken G M B Process for the manufacture of improved fillers or supports and products obtained
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
DE2028224A1 (en) * 1969-06-10 1970-12-17 Solco Basel AG, Basel (Schweiz)j Orally applicable drug form
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US4013820A (en) * 1974-11-07 1977-03-22 Abbott Laboratories Universally useable tableting ingredients
SE426548B (en) * 1978-12-05 1983-01-31 Haessle Ab SOLID PHARMACEUTICAL PREPARATION INCLUDING A THERAPEUTICALLY EFFECTIVE HEART GYCLOSIDE AND POLYMER
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
SE7813246L (en) * 1978-12-22 1980-06-23 Haessle Ab FIXED PHARMACEUTICAL PREPARATION INCLUDING BODIES WITH MULTIPLE LAYERS
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (en) * 1980-03-20 1982-03-11
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
IT1200217B (en) * 1986-09-30 1989-01-05 Valducci Roberto MEMBRANE FOR PHARMACEUTICAL AND INDUSTRIAL USE
US4752470A (en) * 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
GB8707740D0 (en) * 1987-04-01 1987-05-07 Strathclyde Minerals Ltd Composition
FI77573C (en) * 1987-05-08 1989-04-10 Orion Yhtymae Oy New texture.
US4961932A (en) * 1987-10-26 1990-10-09 Alza Corporation Plurality of tiny pills in liquid dosage form
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
JP2643222B2 (en) * 1988-02-03 1997-08-20 エーザイ株式会社 Multi-layer granules
US5059416A (en) * 1989-06-26 1991-10-22 Warner-Lambert Company Zinc compound delivery system with improved taste and texture
ATE114472T1 (en) * 1989-09-21 1994-12-15 American Cyanamid Co ''ONCE DAILY'' PULSED MINOCYCLINE DELIVERY SYSTEM.
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
GB0213192D0 (en) * 2002-06-08 2002-07-17 Bruce William R Oral compositions
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
FR2986431B1 (en) * 2012-02-03 2017-03-17 Servier Lab PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2881085A (en) * 1953-11-09 1959-04-07 Abbott Lab Thin film coating for tablets and the like
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
BE556141A (en) * 1956-03-27
US2956926A (en) * 1958-09-23 1960-10-18 American Cyanamid Co Coated citric acid particles
US2954323A (en) * 1958-10-06 1960-09-27 Abbott Lab Thin film coating for tablets and the like
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill

Also Published As

Publication number Publication date
CH423100A (en) 1966-10-31
DE1467961A1 (en) 1970-04-16
NL270408A (en)
BE659324A (en) 1965-05-28
GB935602A (en) 1963-08-28
US3080294A (en) 1963-03-05

Similar Documents

Publication Publication Date Title
FI41523B (en)
FR1310141A (en)
DK122491B (en)
IT649740A (en)
FR1317920A (en)
FR1310136A (en)
FI41260B (en)
FR825M (en)
FI40863B (en)
FR79M (en)
FR1601711A (en)
BE611163A (en)
BE609798A (en)
NL122039C (en)
BE609856A (en)
BE609291A (en)
BE608772A (en)
BE604898A (en)
BE603666A (en)
BE602562A (en)
BE600627A (en)
BE611989A (en)
BE611983A (en)
BE611246A (en)
BE602010A (en)